Details of the Drug Reposition

General Information of This Drug (ID: DMOT705)

Drug Name
MultiStem   DMOT705
Synonyms MultiStem (TN)

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ischemic stroke DISYV7YJ 8B11.5Z Phase 3 [1]
------------------------------------------------------------------------------------
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
AIDS-related lymphoma DISSLRAU 2B33.5 Phase 2 [2]
Graft-versus-host disease DIS0QADF 4B24 Phase 2 [2]
Acute myocardial infarction DISE3HTG BA41 Phase 2 [3]
Spinal cord injury DISOR9PQ ND51.2 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03545607) MultiStem Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02277613) A Phase 2 Trial of AMI MultiStem Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction. U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)